Ethionamide is a prodrug[REF] which is activated by the enzyme ethA, a mono-oxygenase in Mycobacterium tuberculosis, and then binds NAD+ to form an adduct which inhibits InhA in the same way as isoniazid.
Expression of the ethA gene is controlled by ethR, a transcriptional repressor.